A recently unsealed lawsuit alleges sales reps from Medtronic, the world’s largest medical equipment company, operated a bribery scheme at a Kansas hospital.

Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...

Rockville, MD, Oct. 28, 2024 (GLOBE NEWSWIRE) -- The global peripheral stent implant market is set to be valued at US$ 4.11 billion in 2024 and is projected to expand at 6.6% CAGR from 2024 to 2034.

and will compare it to an historical control group of patients that have received drug-eluting stents through Medtronic’s prior clinical studies of its Resolute Onyx implant. Participants in ...

Endospan has completed enrollment in the primary arm of a clinical trial evaluating its stent graft for the treatment of ...

Medtronic announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.

The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...

Alert FDA: No Excess Mortality Risk From Paclitaxel PAD Devices The statement comes 4 years after the agency's first warnings of a mortality risk from paclitaxel-based peripheral stents and ...

Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation ...

Peripheral vascular devices are of significant importance in the management and treatment of vascular diseases affecting veins and arteries other than the brain ones. These include stents ...

The growth of the stent graft balloon catheter market is primarily driven by the increasing prevalence of cardiovascular ...